Inovio Pharmaceuticals

(NASDAQ) INO

Current Price$1.10

Market Cap$88.86M

Since IPO (1998)-100%

5 Year-99%

1 Year-51%

1 Month-12%

Inovio Pharmaceuticals Financials at a Glance

Market Cap

$88.86M

Revenue (TTM)

$0.00

Net Income (TTM)

-$84.93M

EPS (TTM)

-$1.71

P/E Ratio

-0.63

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$1.10

Volume

1,194,902.702

Open

$1.08

Price

$1.10

Volume

1,194,902.702

Open

$1.08

Previous Close

$1.10

Daily Range

$1.08 - $1.12

52-Week Range

$1.03 - $2.98

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$1.10

Volume

1,194,902.702

Open

$1.08

Previous Close

$1.10

Daily Range

$1.08 - $1.12

52-Week Range

$1.03 - $2.98

Estimated Earnings Date

Aug 12, 2026

INO News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Inovio Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

112

CEO

Jacqueline E. Shea, PhD

Website

www.inovio.com

Headquarters

Plymouth Meeting, PA 19462, US

INO Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-666.47%

Return on Capital

-259.45%

Return on Assets

-170.63%

Earnings Yield

-1.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$88.86M

Shares Outstanding

82.27M

Volume

1.19M

Avg. Volume

2.80M

Financials (TTM)

Gross Profit

-$2.24M

Operating Income

-$83.72M

EBITDA

-$81.94M

Operating Cash Flow

-$83.35M

Capital Expenditure

-$226.33K

Free Cash Flow

-$83.57M

Cash & ST Invst.

$37.68M

Total Debt

$8.70M

Inovio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$745.46K

-1240.8%

Gross Margin

0.00%

N/A

Market Cap

$88.86M

N/A

Market Cap/Employee

$663.10K

N/A

Employees

134

N/A

Net Income

-$19.68M

+0.1%

EBITDA

-$18.94M

+0.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$37.68M

-44.9%

Total Debt

$8.70M

-22.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$5.79M

-33.5%

Short Term Debt

$2.91M

+12.9%

Return on Assets

-1.71%

N/A

Return on Invested Capital

-7.06%

N/A

Free Cash Flow

-$21.59M

+19.8%

Operating Cash Flow

-$21.59M

+19.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SEERSeer, Inc.

SEERSeer, Inc.$1.66-4.05%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.08+3.43%

AGENAgenus Inc.

AGENAgenus Inc.$3.03+5.21%

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.26+11.88%

ACTUActuate Therapeutics Inc

ACTUActuate Therapeutics Inc$1.68-14.29%

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.36+6.79%

VTGNVistaGen Therapeutics, Inc.

VTGNVistaGen Therapeutics, Inc.$0.70+13.85%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.88+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

NWLNewell Brands

NWLNewell Brands$5.82-0.01%

Questions About INO

What is the current price of Inovio Pharmaceuticals?

Inovio Pharmaceuticals is trading at $1.10 per share.

What is the 52-week range for Inovio Pharmaceuticals?

Over the past 52 weeks, Inovio Pharmaceuticals has traded between $1.03 and $2.98.

How much debt does Inovio Pharmaceuticals have?

As of the most recent reporting period, Inovio Pharmaceuticals reported total debt of $8.70M.

How much cash does Inovio Pharmaceuticals have on hand?

Inovio Pharmaceuticals reported $26.27M in cash and cash equivalents in its most recent financial results.

What is Inovio Pharmaceuticals’s dividend yield?

Inovio Pharmaceuticals does not currently have a dividend yield.

Inovio Pharmaceuticals

Inovio Pharmaceuticals Financials at a Glance

INO News

Is Inovio Pharmaceuticals Stock Going to $0?

Inovio Cuts Q2 Losses by 27%

This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?

Why Inovio Pharmaceuticals' Shares Jumped on Thursday

Why Shares of Inovio Pharmaceuticals Were Down Tuesday

2 Stocks to Sell or Remove From Your Watchlist in 2023

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today

Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Inovio Pharmaceuticals

INO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Inovio Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INO

What is the current price of Inovio Pharmaceuticals?

What is the 52-week range for Inovio Pharmaceuticals?

How much debt does Inovio Pharmaceuticals have?

How much cash does Inovio Pharmaceuticals have on hand?

What is Inovio Pharmaceuticals’s dividend yield?

Premium Investing Services